Glaxo's Avandia Cleared From Marketing Limits by U.S. Regulators

GlaxoSmithKline Plc's much-maligned diabetes drug Avandia will be released from restrictions preventing sales to certain patients after U.S. regulators determined new data show the medicine doesn't raise heart risks.

http://washpost.bloomberg.com/Story?docId=1376-MWU3N06KLVRI01-4MQO24J8HN0LCUQAMV4NVJ2B87